# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001517022-26-000020
Filing Date
2026-02-26
Accepted
2026-02-26 07:35:08
Documents
125
Period of Report
2025-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | akba-20251231.htm iXBRL | 10-K | 3401227
2 | EX-10.10 | ex1010180citypoint-akebial.htm | EX-10.10 | 685659
3 | EX-10.11 | ex10115thamended-restatedn.htm | EX-10.11 | 28481
4 | EX-10.14 | ex1014akebia-amendedandres.htm | EX-10.14 | 88723
5 | EX-10.16 | ex1016akbaesa-nonxceocxlev.htm | EX-10.16 | 78220
6 | EX-10.42 | ex10422023plannewformofoff.htm | EX-10.42 | 63395
7 | EX-10.43 | ex10432023plannewformofoff.htm | EX-10.43 | 59774
8 | EX-10.44 | ex10442023plannewformofoff.htm | EX-10.44 | 61297
9 | EX-10.45 | ex10452023plannewformofoff.htm | EX-10.45 | 57920
10 | EX-10.91 | ex1091akebiaamendment1medi.htm | EX-10.91 | 44074
11 | EX-10.96 | ex1096akebiaq32assetpurcha.htm | EX-10.96 | 738838
12 | EX-10.97 | ex1097akebiacyclerionlicen.htm | EX-10.97 | 440245
13 | EX-10.98 | ex1098akebiaamendment1-cyc.htm | EX-10.98 | 63603
14 | EX-23.1 | ex231eyconsent1.htm | EX-23.1 | 9907
15 | EX-31.1 | akbaex31112312025-10xk.htm | EX-31.1 | 10735
16 | EX-31.2 | akbaex31212312025-10xk.htm | EX-31.2 | 10823
17 | EX-32.1 | akbaex32112312025-10xk.htm | EX-32.1 | 8721
23 | GRAPHIC | akba-20251231_g1.gif | GRAPHIC | 3995
24 | GRAPHIC | akba-20251231_g2.gif | GRAPHIC | 122074
| Complete submission text file | 0001517022-26-000020.txt |  | 17260973

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | akba-20251231.xsd | EX-101.SCH | 109454
19 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | akba-20251231_cal.xml | EX-101.CAL | 126586
20 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | akba-20251231_def.xml | EX-101.DEF | 462035
21 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | akba-20251231_lab.xml | EX-101.LAB | 1117447
22 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | akba-20251231_pre.xml | EX-101.PRE | 808964
128 | EXTRACTED XBRL INSTANCE DOCUMENT | akba-20251231_htm.xml | XML | 1864870

Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36352 | Film No.: 26681725
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)